TNXP tonixpharma.com: Operating Sales Margin

Brandmark of Tonix Pharmaceuticals Holding (TNXP)

The Tonix Pharmaceuticals (TNXP) portfolio spans neurology and immunology but remains subject to binary clinical trial risks. Formula synergy is generated through partnerships with US Department of Defense centers. The operating profit margin demonstrates internal efficiency, with the current level of the indicator standing at -436.20. The business relies on the development of vaccines and fibromyalgia treatments for healthcare systems and pharmacy chains.

TNXP - Tonix Pharmaceuticals Holding Corp. Operating Profit Rate over the range 07/04/2022 - 11/20/2026

Tonix Pharmaceuticals - analytical breakdowns and key metrics (TNXP)

- share price and consensus valuation forecast:
Basic company analysis:TNXP, Tonix Pharmaceuticals Inc.
Finished products of Tonix Pharmaceuticals Holding

Operating margin measures the proportion of profit from core operations relative to total revenue before accounting for financial expenses and taxes. This ratio determines the internal efficiency of the business model and the company's ability to generate cash flow. By analyzing the dynamics of operational efficiency, an investor can discern the real value of assets. For Tonix Pharmaceuticals (TNXP), negative values confirm a critical liquidity deficit, leaving the company dependent on equity offerings to fund drug launches.

Competitor analysis for Tonix Pharmaceuticals

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.